Contract manufacturer Catalent to double Moderna's Covid-19 vaccine production
The agreement will nearly double the vaccine output at Catalent's Bloomington, Indiana, plant this month to about 400 vials a minute
FILE PHOTO: Vials with a sticker reading "Covid-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Contract manufacturer Catalent Inc has reached an agreement with Moderna Inc to expand the US production of the vaccine maker's Covid-19 shot, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
The agreement will nearly double the vaccine output at Catalent's Bloomington, Indiana, plant this month to about 400 vials a minute, WSJ reported.
Keep updated, follow The Business Standard's Google news channel
